Insider Selling: Phreesia, Inc. (NYSE:PHR) Director Sells 2,802 Shares of Stock

Phreesia, Inc. (NYSE:PHR - Get Free Report) Director Lisa Egbuonu-Davis sold 2,802 shares of Phreesia stock in a transaction dated Thursday, June 26th. The shares were sold at an average price of $27.67, for a total transaction of $77,531.34. Following the completion of the transaction, the director directly owned 22,037 shares of the company's stock, valued at approximately $609,763.79. This trade represents a 11.28% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Phreesia Trading Down 0.1%

Shares of Phreesia stock traded down $0.02 during trading on Monday, hitting $28.47. The company's stock had a trading volume of 1,299,710 shares, compared to its average volume of 454,354. The stock has a market cap of $1.69 billion, a price-to-earnings ratio of -38.47 and a beta of 0.68. Phreesia, Inc. has a 52 week low of $17.07 and a 52 week high of $30.53. The stock has a 50-day moving average price of $25.64 and a two-hundred day moving average price of $26.15. The company has a debt-to-equity ratio of 0.02, a current ratio of 1.95 and a quick ratio of 1.95.

Phreesia (NYSE:PHR - Get Free Report) last released its quarterly earnings results on Wednesday, May 28th. The company reported ($0.07) EPS for the quarter, beating analysts' consensus estimates of ($0.13) by $0.06. Phreesia had a negative return on equity of 16.23% and a negative net margin of 9.83%. The firm had revenue of $115.94 million for the quarter, compared to analyst estimates of $115.00 million. During the same quarter in the previous year, the company posted ($0.05) EPS. The business's revenue was up 14.5% on a year-over-year basis. Equities research analysts anticipate that Phreesia, Inc. will post -1.1 EPS for the current fiscal year.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in PHR. Johnson Financial Group Inc. raised its stake in Phreesia by 381.3% during the fourth quarter. Johnson Financial Group Inc. now owns 1,131 shares of the company's stock worth $28,000 after buying an additional 896 shares during the last quarter. Quarry LP raised its position in shares of Phreesia by 210.9% in the 4th quarter. Quarry LP now owns 2,835 shares of the company's stock worth $71,000 after acquiring an additional 1,923 shares in the last quarter. KBC Group NV bought a new position in shares of Phreesia in the 1st quarter worth about $74,000. Smartleaf Asset Management LLC lifted its stake in shares of Phreesia by 154.6% in the 4th quarter. Smartleaf Asset Management LLC now owns 3,442 shares of the company's stock valued at $89,000 after purchasing an additional 2,090 shares during the period. Finally, CWM LLC lifted its stake in shares of Phreesia by 994.9% in the 1st quarter. CWM LLC now owns 4,040 shares of the company's stock valued at $103,000 after purchasing an additional 3,671 shares during the period. Institutional investors own 92.10% of the company's stock.

Wall Street Analysts Forecast Growth

Several brokerages have issued reports on PHR. Citigroup restated a "buy" rating on shares of Phreesia in a research report on Wednesday, May 28th. Wall Street Zen upgraded shares of Phreesia from a "hold" rating to a "buy" rating in a research report on Sunday, June 1st. Truist Financial boosted their price target on Phreesia from $34.00 to $35.00 and gave the company a "buy" rating in a research note on Thursday, May 29th. DA Davidson lowered their price objective on Phreesia from $36.00 to $34.00 and set a "buy" rating on the stock in a research note on Monday, April 14th. Finally, KeyCorp dropped their price objective on Phreesia from $30.00 to $28.00 and set an "overweight" rating for the company in a report on Wednesday, April 16th. Twelve equities research analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, Phreesia currently has a consensus rating of "Buy" and an average price target of $31.64.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.